Trial Profile
A multicentre, double-blind, vehicle-controlled, randomised group-comparative study to evaluate the efficacy and safety of Altoderm, a topically-applied sodium cromoglicate lotion, in the treatment of atopic dermatitis in children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Sep 2019
Price :
$35
*
At a glance
- Drugs Sodium cromoglicate (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Thornton & Ross
- 31 Jul 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 07 May 2009 New trial record